Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma-Reference-Cited by-同舟云学术

Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma

Published:2018-01-29 Issue:4 Volume:50 Page:515-523
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Zeid Rhamy,Lawlor Matthew A.,Poon Evon,Reyes Jaime M.,Fulciniti Mariateresa,Lopez Michael A.,Scott Thomas G.,Nabet Behnam^ORCID,Erb Michael A.^ORCID,Winter Georg E.,Jacobson Zoe,Polaski Donald R.,Karlin Kristen L.,Hirsch Rachel A.,Munshi Nikhil P.,Westbrook Thomas F.,Chesler Louis^ORCID,Lin Charles Y.^ORCID,Bradner James E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/s41588-018-0044-9.pdf

Reference66 articles.

1. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899–905 (2010).

2. Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004–3016 (1999).

3. Matthay, K. K., George, R. E. & Yu, A. L. Promising therapeutic targets in neuroblastoma. Clin. Cancer Res. 18, 2740–2753 (2012).

4. Seeger, R. C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111–1116 (1985).

5. Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. & Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985–2995 (1997).

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells;Neoplasia;2024-11

2. EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate;Journal of Controlled Release;2024-10

3. MYC shapes ER-mitochondria calcium transfer by directly targetingITPR1: implications for MYC-induced safeguard mechanisms and cancer;2024-08-28

4. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

5. GDP-mannose 4,6-Dehydratase is a Key Driver of MYCN-amplified Neuroblastoma Core Fucosylation and Tumorigenesis;2024-08-11